Medical Devices US

US Spinal Cord Stimulation Market Analysis, 2024–2034

US Spinal Cord Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.25 Bn Estimated value
Estimate 2025 $1.32 Bn 37.7% of the global market
Projected 2034 $2.16 Bn 63.3% Adds $835.9 Mn over 9 forecast years
CAGR 2025–2034 5.6% Faster than 39% of 173 Medical Devices markets here
Key players 5
  • US is 37.74% of the global market.
  • In North America, the largest is US (this report) at $1.32 Bn.
  • Fastest growing: Canada at 8.1% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$835.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Spinal Cord Stimulation Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.25 Bn — —
2025 (base) $1.32 Bn +$70.0 Mn —
2026 (forecast) $1.39 Bn +$74.0 Mn +5.6%
2027 (forecast) $1.47 Bn +$78.1 Mn +11.5%
2028 (forecast) $1.56 Bn +$82.5 Mn +17.8%
2029 (forecast) $1.64 Bn +$87.1 Mn +24.4%
2030 (forecast) $1.73 Bn +$92.0 Mn +31.3%
2031 (forecast) $1.83 Bn +$97.1 Mn +38.7%
2032 (forecast) $1.93 Bn +$102.5 Mn +46.4%
2033 (forecast) $2.04 Bn +$108.3 Mn +54.6%
2034 (forecast) $2.16 Bn +$114.4 Mn +63.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.50 Bn
  2. North America $1.88 Bn
  3. US (this report) $1.32 Bn
  4. APAC $804.4 Mn
  5. Europe $692.1 Mn
  6. China $318.3 Mn
  7. Canada $292.1 Mn
  8. Japan $239.6 Mn
  9. Latin America $180.2 Mn
  10. Middle East $162.9 Mn
  11. Germany $133.2 Mn
  12. UK $96.0 Mn
  13. Brazil $98.1 Mn
  14. France $93.1 Mn
  15. Italy $81.3 Mn
  16. Ecuador $80.4 Mn
  17. India $74.6 Mn
  18. Saudi Arabia $68.5 Mn
  19. Spain $63.3 Mn
  20. Mexico $59.7 Mn
  21. Africa $58.6 Mn
  22. Australia $46.3 Mn
  23. Russia $38.2 Mn
  24. New Zealand $32.1 Mn
  25. South Africa $23.3 Mn
  26. UAE $16.8 Mn
  27. Egypt $10.3 Mn
  28. Philippines $7.2 Mn
  29. Hong Kong $5.6 Mn
  30. Malaysia $5.3 Mn
  31. Singapore $4.1 Mn
  32. Thailand $3.9 Mn
  33. Kenya $2.6 Mn

The US Spinal Cord Stimulation Market Analysis Executive Summary

Spinal cord stimulation sends mild electrical pulses to the spinal cord to block chronic pain signals.

Key segments of the spinal Cord Stimulation market include product (Rechargeable, Non-Rechargeable and Closed-Loop) and indication (Failed Back Surgery, Diabetic Neuropathy and Complex Regional Pain).

US Spinal Cord Stimulation Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the spinal Cord Stimulation market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the spinal Cord Stimulation market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the spinal Cord Stimulation market.

Competitive Landscape for Spinal Cord Stimulation Market in US

The spinal Cord Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Spinal Cord Stimulation Market in US

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how spinal Cord Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Spinal Cord Stimulation right now, from free public sources.

Clinical trials

172 active trials in the US

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Nevro 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Saluda Medical 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Presidio Medical, Inc 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Boston Scientific Corporation 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 2,338 papers since 2021 (worldwide)

  1. Association of documented hypersensitivity phenotypes with spinal cord stimulation treatment durability: A retrospective cohort study. Clinical neurology and neurosurgery, 2026
  2. Acute Effects of Transcutaneous Spinal Cord Stimulation on Gait Symmetry in People With Chronic Stroke. Neuromodulation : journal of the International Neuromodulation Society, 2026
  3. Flexible recording electrodes preliminarily reveal the brain-spinal circuit mechanism of spinal cord stimulation in the treatment of motor impairment in the mouse model of Parkinson's disease. Science China. Life sciences, 2026
  4. Filtering spinal cord stimulation artifacts while preserving muscle activity during exoskeleton assisted walking after spinal cord injury. BMC research notes, 2026
  5. Pudendal Neuralgia in a Tertiary Pain Clinic: Presentation, Treatment, and Factors Associated with Neuromodulation in 224 Adults. Pain and therapy, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Spinal Cord Stimulation in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How many clinical trials on Spinal Cord Stimulation are running in the US?
172 studies are recruiting, active or about to start in the US.[4]
How much research is published on Spinal Cord Stimulation?
PubMed lists 2,338 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Spinal Cord Stimulation in US? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Alzheimer's Diagnosis: Blood Tests and Earlier Answers57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help… Cannabis-Based Medicines: Science and RegulationThe FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Back to Catalogue
Keep exploring

Related Medical Devices reports in US

See all
Same topic, other categories

Related on brain and nerves and pain

See the topic